炎症性肠病及其他疾病中的肠道病毒组
本综述总结肠道病毒组研究最新进展,重点阐述病毒组与黏膜微环境的交互作用,探讨前沿技术如何推动该领域研究,并概述病毒组移植及基于病毒组的创新治疗在改善临床管理中的开发前景。
要点
- 肠道病毒组失调主要由有尾噬菌体目扩增驱动,可影响肠道免疫与屏障功能。
- 病毒组失调是因果事件还是伴随现象,仍需进一步阐明。
- 新兴技术尚需进一步实施,但已显示刻画病毒组组成及其在肠道疾病中作用的前所未有能力。
核心结论
- 肠道病毒组领域正逐步扩展,测序技术与生物信息学流程的进步增进了对病毒组失调与肠道疾病发病机制关联及病毒组组成调控辅助临床干预的理解。
研究设计与样本
- 本综述旨在总结肠道病毒组研究的最新进展,重点阐述其与黏膜微环境的交互作用。
- 综述探讨前沿技术如何基于现有知识推进该领域研究,并概述病变胃肠道中的病毒组移植及基于病毒组的创新治疗开发。
主要发现
- 肠道病毒组失调主要由有尾噬菌体目(Caudovirales)扩增驱动,已显示可影响肠道免疫与屏障功能,进而影响整体肠道稳态。
- 新兴创新技术尚需进一步实施,但已显示前所未有的潜力,可更好地刻画病毒组组成并界定其在肠道疾病中的作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 病毒组失调是因果事件还是伴随现象,仍需进一步阐明。
- 新兴创新技术仍需要进一步实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The gut virome is a dense community of viruses inhabiting the gastrointestinal tract and an integral part of the microbiota. The virome coexists with the other components of the microbiota and with the host in a dynamic equilibrium, serving as a key contributor to the maintenance of intestinal homeostasis and functions. However, this equilibrium can be interrupted in certain pathological states, including inflammatory bowel disease, causing dysbiosis that may participate in disease pathogenesis. Nevertheless, whether virome dysbiosis is a causal or bystander event requires further clarification. DESIGN: This review seeks to summarise the latest advancements in the study of the gut virome, highlighting its cross-talk with the mucosal microenvironment. It explores how cutting-edge technologies may build upon current knowledge to advance research in this field. An overview of virome transplantation in diseased gastrointestinal tracts is provided along with insights into the development of innovative virome-based therapeutics to improve clinical management. RESULTS: Gut virome dysbiosis, primarily driven by the expansion of Caudovirales, has been shown to impact intestinal immunity and barrier functions, influencing overall intestinal homeostasis. Although emerging innovative technologies still need further implementation, they display the unprecedented potential to better characterise virome composition and delineate its role in intestinal diseases. CONCLUSIONS: The field of gut virome is progressively expanding, thanks to the advancements of sequencing technologies and bioinformatic pipelines. These have contributed to a better understanding of how virome dysbiosis is linked to intestinal disease pathogenesis and how the modulation of virome composition may help the clinical intervention to ameliorate gut disease management.
引用
- Tun HM, Peng Y, Massimino L, et al. Gut virome in inflammatory bowel disease and beyond. Gut. 2024. PMID: 37949638. doi:10.1136/gutjnl-2023-330001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。